DrugInfoSys

Calcium Glycerophosphate

Also known as: Calcium Glycerinophosphate

Drug #1393

Calcium is used in the managemnent of hypocalcaemia and calcium deficiency states as a result of dietary deficiency or aging.

← Previous drugNext drug →

Primary Characteristics

Calcium Glycerophosphate is also known as Calcium Glycerinophosphate.

It is of Synthetic origin and belongs to Calcium salt.

Molecular Weight: 210.1 · Solubility in Water: sparingly soluble · Solubility in Alcohol: insoluble · Non-proprietary name: Calcium Glycerophosphate.

Molecular structure of Calcium Glycerophosphate

Pharmacokinetics

None recorded.

Advertisement

Indications

Calcium Glycerophosphate is primarily indicated in conditions like Calcium deficiency state, Hypocalcaemia, Osteoporosis prophylaxis.

Calcium Glycerophosphate is also indicated for secondary conditions like Cardiopulmonary resuscitation, Severe hyperkalaemia, Severe hypermagnesaemia.

Contraindications

Calcium Glycerophosphate is contraindicated in conditions like Hypercalcaemia, Renal calculi.

Dosage

None recorded.

Drug Interactions

None recorded.

Side Effects

Calcium Glycerophosphate in overdosage may give rise to further complications which include Sinus bradycardia , Hypotension , Hypercalcemia .

Calcium Glycerophosphate produces potentially life-threatening effects which include Coma, Cardiac Arrest . Careful monitoring is needed with proper medical management.

Calcium Glycerophosphate is known to cause more or less tolerable side effects which are usually transient. These include Abdominal pain, Constipation , GI irritation, Local reactions, Muscle weakness, Nausea, Polyuria, Syncope , Vomiting .

Warnings / Precautions

Calcium glycerophosphate should be used with caution in patients with impaired renal function, pre-existing cardiac arrhythmias, dehydration, diarrhoea, malabsorption or diseases associated with elevated vitamin D concentrations such as sarcoidosis. Generally calcium salts should be avoided in patients with calcium renal calculi. Plasma-calcium concentrations should be monitored closely in patients with renal insufficiency and during parentral administration and if large doses of vitamin D are used.

Available Brands

Click on a strength to view available brands.

Multi-Ingredient Combinations

Caps
25 mg35 mg
Sachet
373.3 mg400 mg560 mg
Syrup
0.0215 mg/5ml23 mg/5ml500 mg/5ml8.333 mg/5ml
Syrup
20 mg/4ml20 mg/5ml25 mg/5ml4.5 mg/5ml41 mg/5ml
Tabs
35 mg350 mg373.3 mg41 mg
Tabs efr
50 mg

Storage Conditions

Calcium Glycerophosphate should be stored Syrups,tabs,caps,powder.

Drug Classification

  1. 1.27 — Vitamins, minerals, tonics, and other susbstances

Manufacturers